DPP3-Based Biotherapy in Cardiogenic Shock
We Recommend
Disclosures
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:
- Grant Support/Research Contract - CSL Vifor
- Consultant Fee/Honoraria/Speaker's Bureau - CSL Vifor; Pharmacosmos
- Chief Medical Officer - 4TEEN4 Pharmaceuticals
- Industry Salary/Salary Support/Employee (full time or part time) - 4TEEN4 Pharmaceuticals